{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:26:37Z","timestamp":1793172397977,"version":"4.5.0"},"reference-count":167,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1038\/s41585-025-01070-2","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T17:27:06Z","timestamp":1754328426000},"page":"13-28","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The state of the art in artificial intelligence and digital pathology in prostate cancer"],"prefix":"10.1038","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0881-7245","authenticated-orcid":false,"given":"Heyuan Michael","family":"Ni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramez","family":"Kouzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Sabbagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael K.","family":"Rooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0606-2160","authenticated-orcid":false,"given":"Simon P.","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif M.","family":"Gadoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakaria","family":"El Kouzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8556-4707","authenticated-orcid":false,"given":"Yinyin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5741-0399","authenticated-orcid":false,"given":"Anant","family":"Madabhushi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama","family":"Mohamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"key":"1070_CR1","first-page":"14","volume":"9","author":"RY Choi","year":"2020","unstructured":"Choi, R. Y., Coyner, A. S., Kalpathy-Cramer, J., Chiang, M. F. & Campbell, J. P. Introduction to machine learning, neural networks, and deep learning. Transl. Vis. Sci. Technol. 9, 14 (2020).","journal-title":"Transl. Vis. Sci. Technol."},{"key":"1070_CR2","unstructured":"World Medical Association. WMA statement on augmented intelligence in medical care. WMA www.wma.net\/policies-post\/wma-statement-on-augmented-intelligence-in-medical-care\/ (2019)."},{"key":"1070_CR3","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1147\/rd.441.0206","volume":"44","author":"AL Samuel","year":"2000","unstructured":"Samuel, A. L. Some studies in machine learning using the game of checkers. IBM J. Res. Dev. 44, 206\u2013226 (2000).","journal-title":"IBM J. Res. Dev."},{"key":"1070_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41591-018-0316-z","volume":"25","author":"A Esteva","year":"2019","unstructured":"Esteva, A. et al. A guide to deep learning in healthcare. Nat. Med. 25, 24\u201329 (2019).","journal-title":"Nat. Med."},{"key":"1070_CR5","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1056\/NEJMra1814259","volume":"380","author":"A Rajkomar","year":"2019","unstructured":"Rajkomar, A., Dean, J. & Kohane, I. Machine learning in medicine. N. Engl. J. Med. 380, 1347\u20131358 (2019).","journal-title":"N. Engl. J. Med."},{"key":"1070_CR6","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.euo.2023.02.006","volume":"6","author":"A Sabbagh","year":"2023","unstructured":"Sabbagh, A. et al. Development and external validation of a machine learning model for prediction of lymph node metastasis in patients with prostate cancer. Eur. Urol. Oncol. 6, 501\u2013507 (2023).","journal-title":"Eur. Urol. Oncol."},{"key":"1070_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature21056","volume":"542","author":"A Esteva","year":"2017","unstructured":"Esteva, A. et al. Dermatologist-level classification of skin cancer with deep neural networks. Nature 542, 115\u2013118 (2017).","journal-title":"Nature"},{"key":"1070_CR8","doi-asserted-by":"publisher","first-page":"117164","DOI":"10.1016\/j.ejmech.2024.117164","volume":"284","author":"S Ambreen","year":"2025","unstructured":"Ambreen, S., Umar, M., Noor, A., Jain, H. & Ali, R. Advanced AI and ML frameworks for transforming drug discovery and optimization: with innovative insights in polypharmacology, drug repurposing, combination therapy and nanomedicine. Eur. J. Med. Chem. 284, 117164 (2025).","journal-title":"Eur. J. Med. Chem."},{"key":"1070_CR9","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/s41568-018-0016-5","volume":"18","author":"A Hosny","year":"2018","unstructured":"Hosny, A., Parmar, C., Quackenbush, J., Schwartz, L. H. & Aerts, H. J. W. L. Artificial intelligence in radiology. Nat. Rev. Cancer 18, 500\u2013510 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"1070_CR10","doi-asserted-by":"publisher","first-page":"e253","DOI":"10.1016\/S1470-2045(19)30154-8","volume":"20","author":"MKK Niazi","year":"2019","unstructured":"Niazi, M. K. K., Parwani, A. V. & Gurcan, M. N. Digital pathology and artificial intelligence. Lancet Oncol. 20, e253\u2013e261 (2019).","journal-title":"Lancet Oncol."},{"key":"1070_CR11","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/s41591-019-0508-1","volume":"25","author":"G Campanella","year":"2019","unstructured":"Campanella, G. et al. Clinical-grade computational pathology using weakly supervised deep learning on whole slide images. Nat. Med. 25, 1301\u20131309 (2019).","journal-title":"Nat. Med."},{"key":"1070_CR12","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel, R. L., Kratzer, T. B., Giaquinto, A. N., Sung, H. & Jemal, A. Cancer statistics, 2025. CA Cancer J. Clin. 75, 10\u201345 (2025).","journal-title":"CA Cancer J. Clin."},{"key":"1070_CR13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41391-023-00684-0","volume":"27","author":"A Baydoun","year":"2024","unstructured":"Baydoun, A. et al. Artificial intelligence applications in prostate cancer. Prostate Cancer Prostatic Dis. 27, 37\u201345 (2024).","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"1070_CR14","doi-asserted-by":"publisher","first-page":"e407","DOI":"10.1016\/S2589-7500(20)30159-X","volume":"2","author":"L Pantanowitz","year":"2020","unstructured":"Pantanowitz, L. et al. An artificial intelligence algorithm for prostate cancer diagnosis in whole slide images of core needle biopsies: a blinded clinical validation and deployment study. Lancet Digit. Health 2, e407\u2013e416 (2020).","journal-title":"Lancet Digit. Health"},{"key":"1070_CR15","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S1470-2045(19)30738-7","volume":"21","author":"P Str\u00f6m","year":"2020","unstructured":"Str\u00f6m, P. et al. Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study. Lancet Oncol. 21, 222\u2013232 (2020).","journal-title":"Lancet Oncol."},{"key":"1070_CR16","doi-asserted-by":"publisher","first-page":"5378","DOI":"10.3390\/cancers13215378","volume":"13","author":"RN Flach","year":"2021","unstructured":"Flach, R. N. et al. Significant inter- and intralaboratory variation in Gleason grading of prostate cancer: a nationwide study of 35,258 patients in the Netherlands. Cancers 13, 5378 (2021).","journal-title":"Cancers"},{"key":"1070_CR17","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.ccell.2022.09.012","volume":"40","author":"J Lipkova","year":"2022","unstructured":"Lipkova, J. et al. Artificial intelligence for multimodal data integration in oncology. Cancer Cell 40, 1095\u20131110 (2022).","journal-title":"Cancer Cell"},{"key":"1070_CR18","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41571-019-0252-y","volume":"16","author":"K Bera","year":"2019","unstructured":"Bera, K., Schalper, K. A., Rimm, D. L., Velcheti, V. & Madabhushi, A. Artificial intelligence in digital pathology \u2014 new tools for diagnosis and precision oncology. Nat. Rev. Clin. Oncol. 16, 703\u2013715 (2019).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1070_CR19","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41585-019-0193-3","volume":"16","author":"SL Goldenberg","year":"2019","unstructured":"Goldenberg, S. L., Nir, G. & Salcudean, S. E. A new era: artificial intelligence and machine learning in prostate cancer. Nat. Rev. Urol. 16, 391\u2013403 (2019).","journal-title":"Nat. Rev. Urol."},{"key":"1070_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4103\/2153-3539.186902","volume":"7","author":"A Janowczyk","year":"2016","unstructured":"Janowczyk, A. & Madabhushi, A. Deep learning for digital pathology image analysis: a comprehensive tutorial with selected use cases. J. Pathol. Inform. 7, 29 (2016).","journal-title":"J. Pathol. Inform."},{"key":"1070_CR21","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature14539","volume":"521","author":"Y LeCun","year":"2015","unstructured":"LeCun, Y., Bengio, Y. & Hinton, G. Deep learning. Nature 521, 436\u2013444 (2015).","journal-title":"Nature"},{"key":"1070_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s40537-021-00444-8","volume":"8","author":"L Alzubaidi","year":"2021","unstructured":"Alzubaidi, L. et al. Review of deep learning: concepts, CNN architectures, challenges, applications, future directions. J. Big Data 8, 53 (2021).","journal-title":"J. Big Data"},{"key":"1070_CR23","doi-asserted-by":"publisher","first-page":"82031","DOI":"10.1109\/ACCESS.2021.3086020","volume":"9","author":"N Siddique","year":"2021","unstructured":"Siddique, N., Paheding, S., Elkin, C. P. & Devabhaktuni, V. U-net and its variants for medical image segmentation: a review of theory and applications. IEEE Access. 9, 82031\u201382057 (2021).","journal-title":"IEEE Access."},{"key":"1070_CR24","doi-asserted-by":"crossref","unstructured":"He, K., Zhang, X., Ren, S. & Sun, J. Deep residual learning for image recognition in Proc. 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR) 770\u2013778 (IEEE, 2016).","DOI":"10.1109\/CVPR.2016.90"},{"key":"1070_CR25","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1038\/s41379-020-0551-y","volume":"33","author":"P Raciti","year":"2020","unstructured":"Raciti, P. et al. Novel artificial intelligence system increases the detection of prostate cancer in whole slide images of core needle biopsies. Mod. Pathol. 33, 2058\u20132066 (2020).","journal-title":"Mod. Pathol."},{"key":"1070_CR26","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.2869","volume":"11","author":"C Giesen","year":"2014","unstructured":"Giesen, C. et al. Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry. Nat. Methods 11, 417\u2013422 (2014).","journal-title":"Nat. Methods"},{"key":"1070_CR27","doi-asserted-by":"publisher","first-page":"100175","DOI":"10.1016\/j.labinv.2023.100175","volume":"103","author":"J Doyle","year":"2023","unstructured":"Doyle, J. et al. Whole-slide imaging, mutual information registration for multiplex immunohistochemistry and immunofluorescence. Lab. Invest. 103, 100175 (2023).","journal-title":"Lab. Invest."},{"key":"1070_CR28","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1007\/s10278-020-00351-z","volume":"33","author":"N Kumar","year":"2020","unstructured":"Kumar, N., Gupta, R. & Gupta, S. Whole slide imaging (WSI) in pathology: current perspectives and future directions. J. Digit. Imaging 33, 1034\u20131040 (2020).","journal-title":"J. Digit. Imaging"},{"key":"1070_CR29","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.21037\/tau-20-1237","volume":"10","author":"B Rocco","year":"2021","unstructured":"Rocco, B. et al. Current and future perspectives of digital microscopy with fluorescence confocal microscope for prostate tissue interpretation: a narrative review. Transl. Androl. Urol. 10, 1569\u20131580 (2021).","journal-title":"Transl. Androl. Urol."},{"key":"1070_CR30","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/bju.16588","volume":"135","author":"N Mayor","year":"2025","unstructured":"Mayor, N. et al. Fluorescence confocal microscopy for margin assessment in prostatectomy: IP8-FLUORESCE study protocol. BJU Int. 135, 502\u2013509 (2025).","journal-title":"BJU Int."},{"key":"1070_CR31","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3390\/diagnostics12020277","volume":"12","author":"UG Falagario","year":"2022","unstructured":"Falagario, U. G. et al. One-day prostate cancer diagnosis: biparametric magnetic resonance imaging and digital pathology by fluorescence confocal microscopy. Diagnostics 12, 277 (2022).","journal-title":"Diagnostics"},{"key":"1070_CR32","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fmed.2019.00193","volume":"6","author":"A Anghel","year":"2019","unstructured":"Anghel, A. et al. A high-performance system for robust stain normalization of whole-slide images in histopathology. Front. Med. 6, 193 (2019).","journal-title":"Front. Med."},{"key":"1070_CR33","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1109\/38.946629","volume":"21","author":"E Reinhard","year":"2001","unstructured":"Reinhard, E., Adhikhmin, M., Gooch, B. & Shirley, P. Color transfer between images. IEEE Comput. Graph. Appl. 21, 34\u201341 (2001).","journal-title":"IEEE Comput. Graph. Appl."},{"key":"1070_CR34","doi-asserted-by":"crossref","unstructured":"Macenko, M. et al. A method for normalizing histology slides for quantitative analysis in Proc. 2009 IEEE International Symposium on Biomedical Imaging: From Nano to Macro 1107\u20131110 (IEEE, 2009).","DOI":"10.1109\/ISBI.2009.5193250"},{"key":"1070_CR35","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1109\/TMI.2016.2529665","volume":"35","author":"A Vahadane","year":"2016","unstructured":"Vahadane, A. et al. Structure-preserving color normalization and sparse stain separation for histological images. IEEE Trans. Med. Imaging 35, 1962\u20131971 (2016).","journal-title":"IEEE Trans. Med. Imaging"},{"key":"1070_CR36","doi-asserted-by":"publisher","first-page":"100004","DOI":"10.1016\/j.cmpbup.2021.100004","volume":"1","author":"M Salvi","year":"2021","unstructured":"Salvi, M., Molinari, F., Acharya, U. R., Molinaro, L. & Meiburger, K. M. Impact of stain normalization and patch selection on the performance of convolutional neural networks in histological breast and prostate cancer classification. Comput. Methods Prog. Biomed. Update 1, 100004 (2021).","journal-title":"Comput. Methods Prog. Biomed. Update"},{"key":"1070_CR37","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4103\/jpi.jpi_103_20","volume":"12","author":"L Jose","year":"2021","unstructured":"Jose, L., Liu, S., Russo, C., Nadort, A. & Di Ieva, A. Generative adversarial networks in digital pathology and histopathological image processing: a review. J. Pathol. Inform. 12, 43 (2021).","journal-title":"J. Pathol. Inform."},{"key":"1070_CR38","doi-asserted-by":"crossref","unstructured":"Shaban, M. T., Baur, C., Navab, N. & Albarqouni, S. Staingan: stain style transfer for digital histological images in Proc. 2019 IEEE 16th International Symposium on Biomedical Imaging 953\u2013956 (IEEE, 2019).","DOI":"10.1109\/ISBI.2019.8759152"},{"key":"1070_CR39","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1109\/TMI.2015.2476509","volume":"35","author":"BE Bejnordi","year":"2016","unstructured":"Bejnordi, B. E. et al. Stain specific standardization of whole-slide histopathological images. IEEE Trans. Med. Imaging 35, 404\u2013415 (2016).","journal-title":"IEEE Trans. Med. Imaging"},{"key":"1070_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-71420-0","volume":"10","author":"Z Swiderska-Chadaj","year":"2020","unstructured":"Swiderska-Chadaj, Z. et al. Impact of rescanning and normalization on convolutional neural network performance in multi-center, whole-slide classification of prostate cancer. Sci. Rep. 10, 14398 (2020).","journal-title":"Sci. Rep."},{"key":"1070_CR41","doi-asserted-by":"crossref","unstructured":"Zhu, J.-Y., Park, T., Isola, P. & Efros, A. A. Unpaired image-to-image translation using cycle-consistent adversarial networks in Proc. 2017 IEEE International Conference on Computer Vision (ICCV) 2242\u20132251 (IEEE, 2017).","DOI":"10.1109\/ICCV.2017.244"},{"key":"1070_CR42","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1001\/jamadermatol.2019.1735","volume":"155","author":"JK Winkler","year":"2019","unstructured":"Winkler, J. K. et al. Association between surgical skin markings in dermoscopic images and diagnostic performance of a deep learning convolutional neural network for melanoma recognition. JAMA Dermatol. 155, 1135\u20131141 (2019).","journal-title":"JAMA Dermatol."},{"key":"1070_CR43","doi-asserted-by":"crossref","unstructured":"Ali, S., Alham, N. K., Verrill, C. & Rittscher, J. in Proc. 2019 IEEE 16th International Symposium on Biomedical Imaging 928\u2013932 (IEEE, 2019).","DOI":"10.1109\/ISBI.2019.8759322"},{"key":"1070_CR44","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.5111","volume":"3","author":"A Rana","year":"2020","unstructured":"Rana, A. et al. Use of deep learning to develop and analyze computational hematoxylin and eosin staining of prostate core biopsy images for tumor diagnosis. JAMA Netw. Open\u00a03, e205111 (2020).","journal-title":"JAMA Netw. Open"},{"key":"1070_CR45","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1109\/JBHI.2019.2944643","volume":"24","author":"D Karimi","year":"2020","unstructured":"Karimi, D. et al. Deep learning-based Gleason grading of prostate cancer from histopathology images \u2014 role of multiscale decision aggregation and data augmentation. IEEE J. Biomed. Health Inform. 24, 1413\u20131426 (2020).","journal-title":"IEEE J. Biomed. Health Inform."},{"key":"1070_CR46","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1007\/s11831-023-09896-y","volume":"30","author":"GP Kanna","year":"2023","unstructured":"Kanna, G. P., Kumar, S. J. K. J., Parthasarathi, P. & Kumar, Y. A review on prediction and prognosis of the prostate cancer and Gleason grading of prostatic carcinoma using deep transfer learning based approaches. Arch. Comput. Methods Eng. 30, 3113\u20133132 (2023).","journal-title":"Arch. Comput. Methods Eng."},{"key":"1070_CR47","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.media.2016.06.037","volume":"33","author":"A Madabhushi","year":"2016","unstructured":"Madabhushi, A. & Lee, G. Image analysis and machine learning in digital pathology: challenges and opportunities. Med. Image Anal. 33, 170\u2013175 (2016).","journal-title":"Med. Image Anal."},{"key":"1070_CR48","doi-asserted-by":"publisher","unstructured":"Farjam, R., Soltanian-Zadeh, H., Zoroofi, R. A. & Jafari-Khouzani, K. Tree-structured grading of pathological images of prostate. in Proc. SPIE 5747, Medical Imaging 2005: Image Processing (eds Fitzpatrick, J. M. & Reinhardt, J. M.) https:\/\/doi.org\/10.1117\/12.596068 (SPIE, 2005).","DOI":"10.1117\/12.596068"},{"key":"1070_CR49","unstructured":"Naik, S., Doyle, S., Feldman, M., Tomaszewski, J. & Madabhushi, A. Gland segmentation and computerized Gleason grading of prostate histology by integrating low-, high-level and domain specific information. in Proc. 2nd MICCAI Workshop on Microsopic Image Analysis with Applications in Biology (MICCAI, 2007)."},{"key":"1070_CR50","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.media.2010.04.007","volume":"14","author":"JP Monaco","year":"2010","unstructured":"Monaco, J. P. et al. High-throughput detection of prostate cancer in histological sections using probabilistic pairwise Markov models. Med. Image Anal. 14, 617\u2013629 (2010).","journal-title":"Med. Image Anal."},{"key":"1070_CR51","doi-asserted-by":"crossref","unstructured":"Rashid, S. et al. Separation of benign and malignant glands in prostatic adenocarcinoma in Proc. 16th International Conference on Medical Image Computing and Computer-Assisted Intervention (MICCAI) (eds Mori, K. et al.) 461\u2013468 (Springer, 2013).","DOI":"10.1007\/978-3-642-40760-4_58"},{"key":"1070_CR52","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.0442","volume":"2","author":"G Nir","year":"2019","unstructured":"Nir, G. et al. Comparison of artificial intelligence techniques to evaluate performance of a classifier for automatic grading of prostate cancer from digitized histopathologic images. JAMA Netw. Open\u00a02, e190442 (2019).","journal-title":"JAMA Netw. Open"},{"key":"1070_CR53","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/pros.22926","volume":"75","author":"P Waliszewski","year":"2015","unstructured":"Waliszewski, P., Wagenlehner, F., Gattenl\u00f6hner, S. & Weidner, W. On the relationship between tumor structure and complexity of the spatial distribution of cancer cell nuclei: a fractal geometrical model of prostate carcinoma: grading and complexity. Prostate 75, 399\u2013414 (2015).","journal-title":"Prostate"},{"key":"1070_CR54","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.4103\/2153-3539.92030","volume":"2","author":"K Nguyen","year":"2011","unstructured":"Nguyen, K., Jain, A. K. & Sabata, B. Prostate cancer detection: fusion of cytological and textural features. J. Pathol. Inform. 2, S3 (2011).","journal-title":"J. Pathol. Inform."},{"key":"1070_CR55","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1109\/TMI.2009.2012704","volume":"28","author":"P-W Huang","year":"2009","unstructured":"Huang, P.-W. & Lee, C.-H. Automatic classification for pathological prostate images based on fractal analysis. IEEE Trans. Med. Imaging 28, 1037\u20131050 (2009).","journal-title":"IEEE Trans. Med. Imaging"},{"key":"1070_CR56","unstructured":"Food and Drug Administration. The software precertification (pre-cert) pilot program: tailored total product lifecycle approaches and key findings. FDA www.fda.gov\/media\/161815 (2022)."},{"key":"1070_CR57","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1007\/s10115-022-01756-8","volume":"64","author":"X Li","year":"2022","unstructured":"Li, X. et al. Interpretable deep learning: interpretation, interpretability, trustworthiness, and beyond. Knowl. Inf. Syst. 64, 3197\u20133234 (2022).","journal-title":"Knowl. Inf. Syst."},{"key":"1070_CR58","doi-asserted-by":"publisher","unstructured":"Ahern, I. et al. NormLime: wwa new feature importance metric for explaining deep neural networks. Preprint at https:\/\/doi.org\/10.48550\/ARXIV.1909.04200 (2019).","DOI":"10.48550\/ARXIV.1909.04200"},{"key":"1070_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-09954-8","volume":"12","author":"SA Hicks","year":"2022","unstructured":"Hicks, S. A. et al. On evaluation metrics for medical applications of artificial intelligence. Sci. Rep. 12, 5979 (2022).","journal-title":"Sci. Rep."},{"key":"1070_CR60","doi-asserted-by":"publisher","first-page":"713","DOI":"10.21037\/atm.2020.02.44","volume":"8","author":"L Cai","year":"2020","unstructured":"Cai, L., Gao, J. & Zhao, D. A review of the application of deep learning in medical image classification and segmentation. Ann. Transl. Med. 8, 713 (2020).","journal-title":"Ann. Transl. Med."},{"key":"1070_CR61","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/pros.2990160303","volume":"16","author":"M Petein","year":"1990","unstructured":"Petein, M. et al. Characterization of the morphonuclear features and DNA ploidy of prostatic disease. Prostate\u00a016, 199\u2013208 (1990).","journal-title":"Prostate"},{"key":"1070_CR62","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.humpath.2004.05.010","volume":"35","author":"J Diamond","year":"2004","unstructured":"Diamond, J., Anderson, N. H., Bartels, P. H., Montironi, R. & Hamilton, P. W. The use of morphological characteristics and texture analysis in the identification of tissue composition in prostatic neoplasia. Hum. Pathol. 35, 1121\u20131131 (2004).","journal-title":"Hum. Pathol."},{"key":"1070_CR63","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.3390\/cancers13071524","volume":"13","author":"C-H Kim","year":"2021","unstructured":"Kim, C.-H. et al. Artificial intelligence techniques for prostate cancer detection through dual-channel tissue feature engineering. Cancers 13, 1524 (2021).","journal-title":"Cancers"},{"key":"1070_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-13-282","volume":"13","author":"S Doyle","year":"2012","unstructured":"Doyle, S., Feldman, M. D., Shih, N., Tomaszewski, J. & Madabhushi, A. Cascaded discrimination of normal, abnormal, and confounder classes in histopathology: Gleason grading of prostate cancer. BMC Bioinform.\u00a013, 282 (2012).","journal-title":"BMC Bioinform."},{"key":"1070_CR65","doi-asserted-by":"publisher","unstructured":"Han, W. et al. Automatic cancer detection and localization on prostatectomy histopathology images. in Medical Imaging 2018: Digital Pathology (eds Gurcan, M. N. & Tomaszewski, J. E.) https:\/\/doi.org\/10.1117\/12.2292450 (SPIE, 2018).","DOI":"10.1117\/12.2292450"},{"key":"1070_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-33026-5","volume":"8","author":"P Leo","year":"2018","unstructured":"Leo, P. et al. Stable and discriminating features are predictive of cancer presence and Gleason grade in radical prostatectomy specimens: a multi-site study. Sci. Rep. 8, 14918 (2018).","journal-title":"Sci. Rep."},{"key":"1070_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/srep26286","volume":"6","author":"G Litjens","year":"2016","unstructured":"Litjens, G. et al. Deep learning as a tool for increased accuracy and efficiency of histopathological diagnosis. Sci. Rep. 6, 26286 (2016).","journal-title":"Sci. Rep."},{"key":"1070_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-37257-4","volume":"9","author":"W Bulten","year":"2019","unstructured":"Bulten, W. et al. Epithelium segmentation using deep learning in H&E-stained prostate specimens with immunohistochemistry as reference standard. Sci. Rep. 9, 864 (2019).","journal-title":"Sci. Rep."},{"key":"1070_CR69","doi-asserted-by":"publisher","first-page":"128613","DOI":"10.1109\/ACCESS.2020.3008868","volume":"8","author":"L Duran-Lopez","year":"2020","unstructured":"Duran-Lopez, L., Dominguez-Morales, J. P., Conde-Martin, A. F., Vicente-Diaz, S. & Linares-Barranco, A. PROMETEO: A CNN-based computer-aided diagnosis system for WSI prostate cancer detection. IEEE Access. 8, 128613\u2013128628 (2020).","journal-title":"IEEE Access."},{"key":"1070_CR70","doi-asserted-by":"publisher","unstructured":"Bulten, W. & Litjens, G. Unsupervised prostate cancer detection on H&E using convolutional adversarial autoencoders. Preprint at https:\/\/doi.org\/10.48550\/arXiv.1804.0708 (2018).","DOI":"10.48550\/arXiv.1804.0708"},{"key":"1070_CR71","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/path.5662","volume":"254","author":"LM da Silva","year":"2021","unstructured":"da Silva, L. M. et al. Independent real-world application of a clinical-grade automated prostate cancer detection system. J. Pathol. 254, 147\u2013158 (2021).","journal-title":"J. Pathol."},{"key":"1070_CR72","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1038\/s41379-021-00794-x","volume":"34","author":"S Perincheri","year":"2021","unstructured":"Perincheri, S. et al. An independent assessment of an artificial intelligence system for prostate cancer detection shows strong diagnostic accuracy. Mod. Pathol. 34, 1588\u20131595 (2021).","journal-title":"Mod. Pathol."},{"key":"1070_CR73","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.32554","volume":"4","author":"W Huang","year":"2021","unstructured":"Huang, W. et al. Development and validation of an artificial intelligence-powered platform for prostate cancer grading and quantification. JAMA Netw. Open\u00a04, e2132554 (2021).","journal-title":"JAMA Netw. Open"},{"key":"1070_CR74","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/ajcp\/aqaa130","volume":"155","author":"GP Swanson","year":"2021","unstructured":"Swanson, G. P., Trevathan, S., Hammonds, K. A. P., Speights, V. O. & Hermans, M. R. Gleason score evolution and the effect on prostate cancer outcomes. Am. J. Clin. Pathol. 155, 711\u2013717 (2021).","journal-title":"Am. J. Clin. Pathol."},{"key":"1070_CR75","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/PAS.0000000000000820","volume":"41","author":"JI Epstein","year":"2017","unstructured":"Epstein, J. I., Amin, M. B., Reuter, V. E. & Humphrey, P. A. Contemporary Gleason grading of prostatic carcinoma: an update with discussion on practical issues to implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am. J. Surg. Pathol. 41, e1\u2013e7 (2017).","journal-title":"Am. J. Surg. Pathol."},{"key":"1070_CR76","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s00432-008-0388-0","volume":"134","author":"M Burchardt","year":"2008","unstructured":"Burchardt, M. et al. Interobserver reproducibility of Gleason grading: evaluation using prostate cancer tissue microarrays. J. Cancer Res. Clin. Oncol. 134, 1071\u20131078 (2008).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"1070_CR77","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.media.2013.06.002","volume":"17","author":"R Sparks","year":"2013","unstructured":"Sparks, R. & Madabhushi, A. Explicit shape descriptors: novel morphologic features for histopathology classification. Med. Image Anal. 17, 997\u20131009 (2013).","journal-title":"Med. Image Anal."},{"key":"1070_CR78","doi-asserted-by":"crossref","unstructured":"Kallen, H., Molin, J., Heyden, A., Lundstrom, C. & Astrom, K. Towards grading gleason score using generically trained deep convolutional neural networks. in Proc. 2016 IEEE 13th International Symposium on Biomedical Imaging (ISBI) 1163\u20131167 (IEEE, 2016).","DOI":"10.1109\/ISBI.2016.7493473"},{"key":"1070_CR79","doi-asserted-by":"publisher","unstructured":"Zhou, N., Fedorov, A., Fennessy, F., Kikinis, R. & Gao, Y. Large scale digital prostate pathology image analysis combining feature extraction and deep neural network. Preprint at https:\/\/doi.org\/10.48550\/arXiv.1705.02678 (2017).","DOI":"10.48550\/arXiv.1705.02678"},{"key":"1070_CR80","doi-asserted-by":"publisher","unstructured":"Jim\u00e9nez del Toro, O. et al. Convolutional neural networks for an automatic classification of prostate tissue slides with high-grade Gleason score. in Medical Imaging 2017: Digital Pathology (eds Gurcan, M. N. & Tomaszewski, J. E.) https:\/\/doi.org\/10.1117\/12.2255710 (SPIE, 2017).","DOI":"10.1117\/12.2255710"},{"key":"1070_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-02195-1","volume":"11","author":"E Arvaniti","year":"2021","unstructured":"Arvaniti, E. et al. Author correction: Automated Gleason grading of prostate cancer tissue microarrays via deep learning. Sci. Rep. 11, 23032 (2021).","journal-title":"Sci. Rep."},{"key":"1070_CR82","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.euf.2019.11.003","volume":"7","author":"O Kott","year":"2021","unstructured":"Kott, O. et al. Development of a deep learning algorithm for the histopathologic diagnosis and Gleason grading of prostate cancer biopsies: a pilot study. Eur. Urol. Focus\u00a07, 347\u2013351 (2021).","journal-title":"Eur. Urol. Focus"},{"key":"1070_CR83","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.euf.2020.11.001","volume":"7","author":"F Marginean","year":"2021","unstructured":"Marginean, F. et al. An artificial intelligence-based support tool for automation and standardisation of Gleason grading in prostate biopsies. Eur. Urol. Focus\u00a07, 995\u20131001 (2021).","journal-title":"Eur. Urol. Focus"},{"key":"1070_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-66849-2","volume":"10","author":"W Han","year":"2020","unstructured":"Han, W. et al. Histologic tissue components provide major cues for machine learning-based prostate cancer detection and grading on prostatectomy specimens. Sci. Rep. 10, 9911 (2020).","journal-title":"Sci. Rep."},{"key":"1070_CR85","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.3390\/cancers11121860","volume":"11","author":"HS Ryu","year":"2019","unstructured":"Ryu, H. S. et al. Automated Gleason scoring and tumor quantification in prostate core needle biopsy images using deep neural networks and its comparison with pathologist-based assessment. Cancers 11, 1860 (2019).","journal-title":"Cancers"},{"key":"1070_CR86","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/s41379-022-01077-9","volume":"35","author":"M Jung","year":"2022","unstructured":"Jung, M. et al. Artificial intelligence system shows performance at the level of uropathologists for the detection and grading of prostate cancer in core needle biopsy: an independent external validation study. Mod. Pathol. 35, 1449\u20131457 (2022).","journal-title":"Mod. Pathol."},{"key":"1070_CR87","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41746-019-0112-2","volume":"2","author":"K Nagpal","year":"2019","unstructured":"Nagpal, K. et al. Development and validation of a deep learning algorithm for improving Gleason scoring of prostate cancer. NPJ Digit. Med. 2, 48 (2019).","journal-title":"NPJ Digit. Med."},{"key":"1070_CR88","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s43856-021-00005-3","volume":"1","author":"E Wulczyn","year":"2021","unstructured":"Wulczyn, E. et al. Predicting prostate cancer specific-mortality with artificial intelligence-based Gleason grading. Commun. Med. 1, 10 (2021).","journal-title":"Commun. Med."},{"key":"1070_CR89","doi-asserted-by":"publisher","first-page":"101846","DOI":"10.1016\/j.compmedimag.2020.101846","volume":"88","author":"J Silva-Rodr\u00edguez","year":"2021","unstructured":"Silva-Rodr\u00edguez, J., Colomer, A. & Naranjo, V. WeGleNet: A weakly-supervised convolutional neural network for the semantic segmentation of Gleason grades in prostate histology images. Comput. Med. Imaging Graph. 88, 101846 (2021).","journal-title":"Comput. Med. Imaging Graph."},{"key":"1070_CR90","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S1470-2045(19)30739-9","volume":"21","author":"W Bulten","year":"2020","unstructured":"Bulten, W. et al. Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study. Lancet Oncol. 21, 233\u2013241 (2020).","journal-title":"Lancet Oncol."},{"key":"1070_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-07217-0","volume":"12","author":"N Singhal","year":"2022","unstructured":"Singhal, N. et al. A deep learning system for prostate cancer diagnosis and grading in whole slide images of core needle biopsies. Sci. Rep. 12, 3383 (2022).","journal-title":"Sci. Rep."},{"key":"1070_CR92","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.23267","volume":"3","author":"DF Steiner","year":"2020","unstructured":"Steiner, D. F. et al. Evaluation of the use of combined artificial intelligence and pathologist assessment to review and grade prostate biopsies. JAMA Netw. Open\u00a03, e2023267 (2020).","journal-title":"JAMA Netw. Open"},{"key":"1070_CR93","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41379-020-0640-y","volume":"34","author":"W Bulten","year":"2021","unstructured":"Bulten, W. et al. Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists. Mod. Pathol. 34, 660\u2013671 (2021).","journal-title":"Mod. Pathol."},{"key":"1070_CR94","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/path.5898","volume":"257","author":"D Cifci","year":"2022","unstructured":"Cifci, D., Foersch, S. & Kather, J. N. Artificial intelligence to identify genetic alterations in conventional histopathology. J. Pathol. 257, 430\u2013444 (2022).","journal-title":"J. Pathol."},{"key":"1070_CR95","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/s43018-020-0087-6","volume":"1","author":"JN Kather","year":"2020","unstructured":"Kather, J. N. et al. Pan-cancer image-based detection of clinically actionable genetic alterations. Nat. Cancer 1, 789\u2013799 (2020).","journal-title":"Nat. Cancer"},{"key":"1070_CR96","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/s43018-020-0085-8","volume":"1","author":"Y Fu","year":"2020","unstructured":"Fu, Y. et al. Pan-cancer computational histopathology reveals mutations, tumor composition and prognosis. Nat. Cancer 1, 800\u2013810 (2020).","journal-title":"Nat. Cancer"},{"key":"1070_CR97","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/pros.24269","volume":"82","author":"M Nakazawa","year":"2022","unstructured":"Nakazawa, M. Clinical and genomic features of SPOP-mutant prostate cancer. Prostate 82, 260\u2013268 (2022).","journal-title":"Prostate"},{"key":"1070_CR98","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/ng.2279","volume":"44","author":"CE Barbieri","year":"2012","unstructured":"Barbieri, C. E. et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat. Genet. 44, 685\u2013689 (2012).","journal-title":"Nat. Genet."},{"key":"1070_CR99","doi-asserted-by":"publisher","unstructured":"Schaumberg, A. J., Rubin, M. A. & Fuchs, T. J. H&E-stained whole slide image deep learning predicts SPOP mutation state in prostate cancer. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/064279 (2018).","DOI":"10.1101\/064279"},{"key":"1070_CR100","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09559-4","volume":"22","author":"V Dadhania","year":"2022","unstructured":"Dadhania, V. et al. Leveraging artificial intelligence to predict ERG gene fusion status in prostate cancer. BMC Cancer 22, 494 (2022).","journal-title":"BMC Cancer"},{"key":"1070_CR101","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nrurol.2018.9","volume":"15","author":"T Jamaspishvili","year":"2018","unstructured":"Jamaspishvili, T. et al. Clinical implications of PTEN loss in prostate cancer. Nat. Rev. Urol. 15, 222\u2013234 (2018).","journal-title":"Nat. Rev. Urol."},{"key":"1070_CR102","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/s41379-020-00674-w","volume":"34","author":"SA Harmon","year":"2021","unstructured":"Harmon, S. A. et al. High throughput assessment of biomarkers in tissue microarrays using artificial intelligence: PTEN loss as a proof-of-principle in multi-center prostate cancer cohorts. Mod. Pathol. 34, 478\u2013489 (2021).","journal-title":"Mod. Pathol."},{"key":"1070_CR103","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.3390\/cancers13174291","volume":"13","author":"K Cyll","year":"2021","unstructured":"Cyll, K. et al. PTEN and DNA ploidy status by machine learning in prostate cancer. Cancers 13, 4291 (2021).","journal-title":"Cancers"},{"key":"1070_CR104","doi-asserted-by":"publisher","first-page":"100247","DOI":"10.1016\/j.modpat.2023.100247","volume":"36","author":"E Erak","year":"2023","unstructured":"Erak, E. et al. Predicting prostate cancer molecular subtype with deep learning on histopathologic images. Mod. Pathol. 36, 100247 (2023).","journal-title":"Mod. Pathol."},{"key":"1070_CR105","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1158\/0008-5472.CAN-22-3113","volume":"83","author":"M Pizurica","year":"2023","unstructured":"Pizurica, M. et al. Whole slide imaging-based prediction of TP53 mutations identifies an aggressive disease phenotype in prostate cancer. Cancer Res. 83, 2970\u20132984 (2023).","journal-title":"Cancer Res."},{"key":"1070_CR106","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00428-022-03326-3","volume":"481","author":"K Kartasalo","year":"2022","unstructured":"Kartasalo, K. et al. Detection of perineural invasion in prostate needle biopsies with deep neural networks. Virchows Arch. 481, 73\u201382 (2022).","journal-title":"Virchows Arch."},{"key":"1070_CR107","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1080\/21681805.2019.1643913","volume":"53","author":"S Wu","year":"2019","unstructured":"Wu, S. et al. Impact of biopsy perineural invasion on the outcomes of patients who underwent radical prostatectomy: a systematic review and meta-analysis. Scand. J. Urol. 53, 287\u2013294 (2019).","journal-title":"Scand. J. Urol."},{"key":"1070_CR108","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/S1470-2045(15)00361-7","volume":"16","author":"H Gr\u00f6nberg","year":"2015","unstructured":"Gr\u00f6nberg, H. et al. Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study. Lancet Oncol. 16, 1667\u20131676 (2015).","journal-title":"Lancet Oncol."},{"key":"1070_CR109","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/bju.15386","volume":"128","author":"F Wessels","year":"2021","unstructured":"Wessels, F. et al. Deep learning approach to predict lymph node metastasis directly from primary tumour histology in prostate cancer. BJU Int. 128, 352\u2013360 (2021).","journal-title":"BJU Int."},{"key":"1070_CR110","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jclinepi.2021.01.009","volume":"132","author":"M van Smeden","year":"2021","unstructured":"van Smeden, M., Reitsma, J. B., Riley, R. D., Collins, G. S. & Moons, K. G. Clinical prediction models: diagnosis versus prognosis. J. Clin. Epidemiol. 132, 142\u2013145 (2021).","journal-title":"J. Clin. Epidemiol."},{"key":"1070_CR111","first-page":"396","volume":"16","author":"G Lee","year":"2013","unstructured":"Lee, G. et al. Cell orientation entropy (COrE): predicting biochemical recurrence from prostate cancer tissue microarrays. Med. Image Comput. Comput. Assist. Interv. 16, 396\u2013403 (2013).","journal-title":"Med. Image Comput. Comput. Assist. Interv."},{"key":"1070_CR112","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.euf.2016.05.009","volume":"3","author":"G Lee","year":"2017","unstructured":"Lee, G. et al. Nuclear shape and architecture in benign fields predict biochemical recurrence in prostate cancer patients following radical prostatectomy: preliminary findings. Eur. Urol. Focus\u00a03, 457\u2013466 (2017).","journal-title":"Eur. Urol. Focus"},{"key":"1070_CR113","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097954","volume":"9","author":"G Lee","year":"2014","unstructured":"Lee, G. et al. Co-occurring gland angularity in localized subgraphs: predicting biochemical recurrence in intermediate-risk prostate cancer patients. PLoS ONE 9, e97954 (2014).","journal-title":"PLoS ONE"},{"key":"1070_CR114","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13647-8","volume":"10","author":"Y Yamamoto","year":"2019","unstructured":"Yamamoto, Y. et al. Automated acquisition of explainable knowledge from unannotated histopathology images. Nat. Commun. 10, 5642 (2019).","journal-title":"Nat. Commun."},{"key":"1070_CR115","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41746-022-00613-w","volume":"5","author":"A Esteva","year":"2022","unstructured":"Esteva, A. et al. Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials. NPJ Digit. Med. 5, 71 (2022).","journal-title":"NPJ Digit. Med."},{"key":"1070_CR116","doi-asserted-by":"publisher","first-page":"EVIDoa2300023","DOI":"10.1056\/EVIDoa2300023","volume":"2","author":"DE Spratt","year":"2023","unstructured":"Spratt, D. E. et al. Artificial intelligence predictive model for hormone therapy use in prostate cancer. NEJM Evid. 2, EVIDoa2300023 (2023).","journal-title":"NEJM Evid."},{"key":"1070_CR117","doi-asserted-by":"publisher","DOI":"10.1200\/PO.24.00145","volume":"8","author":"JD Tward","year":"2024","unstructured":"Tward, J. D. et al. Prostate cancer risk stratification in NRG Oncology phase III randomized trials using multimodal deep learning with digital histopathology. JCO Precis. Oncol. 8, e2400145 (2024).","journal-title":"JCO Precis. Oncol."},{"key":"1070_CR118","doi-asserted-by":"publisher","DOI":"10.1200\/PO-24-00653","volume":"9","author":"FY Feng","year":"2025","unstructured":"Feng, F. Y. et al. Digital pathology-based multimodal artificial intelligence scores and outcomes in a randomized phase III trial in men with nonmetastatic castration-resistant prostate cancer. JCO Precis. Oncol. 9, e2400653 (2025).","journal-title":"JCO Precis. Oncol."},{"key":"1070_CR119","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.euo.2024.01.004","volume":"7","author":"AE Ross","year":"2024","unstructured":"Ross, A. E. et al. External validation of a digital pathology-based multimodal artificial intelligence architecture in the NRG\/RTOG 9902 phase 3 trial. Eur. Urol. Oncol. 7, 1024\u20131033 (2024).","journal-title":"Eur. Urol. Oncol."},{"key":"1070_CR120","doi-asserted-by":"publisher","first-page":"110618","DOI":"10.1016\/j.radonc.2024.110618","volume":"202","author":"JH Wang","year":"2025","unstructured":"Wang, J. H. et al. Validation of an artificial intelligence-based prognostic biomarker in patients with oligometastatic castration-sensitive prostate cancer. Radiother. Oncol. 202, 110618 (2025).","journal-title":"Radiother. Oncol."},{"key":"1070_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2024.11.009","author":"MC Markowski","year":"2024","unstructured":"Markowski, M. C. et al. Digital pathology-based artificial intelligence biomarker validation in metastatic prostate cancer. Eur. Urol. Oncol. https:\/\/doi.org\/10.1016\/j.euo.2024.11.009 (2024).","journal-title":"Eur. Urol. Oncol."},{"key":"1070_CR122","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1089\/aipo.2024.0004","volume":"1","author":"P Gerrard","year":"2024","unstructured":"Gerrard, P. et al. Analytical validation of a clinical grade prognostic and classification artificial intelligence laboratory test for men with prostate cancer. AI Precis. Oncol. 1, 119\u2013126 (2024).","journal-title":"AI Precis. Oncol."},{"key":"1070_CR123","doi-asserted-by":"publisher","first-page":"S979","DOI":"10.1016\/j.annonc.2024.08.1702","volume":"35","author":"A Bjartell","year":"2024","unstructured":"Bjartell, A. et al. Validation of a digital pathology-based multimodal artificial intelligence (MMAI) prostate biopsy biomarker in a prospective, real-world Swedish prostate cancer (PCa) cohort treated with radical prostatectomy [abstract 1621P]. Ann. Oncol. 35, S979 (2024).","journal-title":"Ann. Oncol."},{"key":"1070_CR124","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.00365","author":"AJ Armstrong","year":"2025","unstructured":"Armstrong, A. J. et al. Development and validation of an artificial intelligence digital pathology biomarker to predict benefit of long-term hormonal therapy and radiotherapy in men with high-risk prostate cancer across multiple phase III trials. J. Clin. Oncol.\u00a0https:\/\/doi.org\/10.1200\/JCO.24.00365 (2025).","journal-title":"J. Clin. Oncol."},{"key":"1070_CR125","doi-asserted-by":"publisher","unstructured":"Xie, W. et al. Supplementary information from: Prostate cancer risk stratification via nondestructive 3D pathology with deep learning\u2013assisted gland analysis. American Association for Cancer Research. Journal ccotribution. https:\/\/doi.org\/10.1158\/0008-5472.26968499 (2024).","DOI":"10.1158\/0008-5472.26968499"},{"key":"1070_CR126","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41551-023-01056-8","volume":"7","author":"RJ Chen","year":"2023","unstructured":"Chen, R. J. et al. Algorithmic fairness in artificial intelligence for medicine and healthcare. Nat. Biomed. Eng. 7, 719\u2013742 (2023).","journal-title":"Nat. Biomed. Eng."},{"key":"1070_CR127","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1038\/s41591-021-01595-0","volume":"27","author":"L Seyyed-Kalantari","year":"2021","unstructured":"Seyyed-Kalantari, L., Zhang, H., McDermott, M. B. A., Chen, I. Y. & Ghassemi, M. Underdiagnosis bias of artificial intelligence algorithms applied to chest radiographs in under-served patient populations. Nat. Med. 27, 2176\u20132182 (2021).","journal-title":"Nat. Med."},{"key":"1070_CR128","doi-asserted-by":"publisher","DOI":"10.1126\/science.aal1053","author":"M Hutson","year":"2017","unstructured":"Hutson, M. Even artificial intelligence can acquire biases against race and gender. Science https:\/\/doi.org\/10.1126\/science.aal1053 (2017).","journal-title":"Science"},{"key":"1070_CR129","doi-asserted-by":"publisher","first-page":"12592","DOI":"10.1073\/pnas.1919012117","volume":"117","author":"AJ Larrazabal","year":"2020","unstructured":"Larrazabal, A. J., Nieto, N., Peterson, V., Milone, D. H. & Ferrante, E. Gender imbalance in medical imaging datasets produces biased classifiers for computer-aided diagnosis. Proc. Natl Acad. Sci. Usa. 117, 12592\u201312594 (2020).","journal-title":"Proc. Natl Acad. Sci. Usa."},{"key":"1070_CR130","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41746-023-00913-9","volume":"6","author":"MD Abr\u00e0moff","year":"2023","unstructured":"Abr\u00e0moff, M. D. et al. Considerations for addressing bias in artificial intelligence for health equity. NPJ Digit. Med. 6, 170 (2023).","journal-title":"NPJ Digit. Med."},{"key":"1070_CR131","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1001\/jamaoncol.2022.5511","volume":"9","author":"IB Riaz","year":"2023","unstructured":"Riaz, I. B. et al. Disparities in the inclusion of racial and ethnic minority groups and older adults in prostate cancer clinical trials: a meta-analysis. JAMA Oncol. 9, 180\u2013187 (2023).","journal-title":"JAMA Oncol."},{"key":"1070_CR132","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1002\/cncr.34433","volume":"128","author":"JW Lillard Jr","year":"2022","unstructured":"Lillard, J. W. Jr, Moses, K. A., Mahal, B. A. & George, D. J. Racial disparities in Black men with prostate cancer: a literature review. Cancer 128, 3787\u20133795 (2022).","journal-title":"Cancer"},{"key":"1070_CR133","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/d41586-018-05707-8","volume":"559","author":"J Zou","year":"2018","unstructured":"Zou, J. & Schiebinger, L. AI can be sexist and racist \u2014 it\u2019s time to make it fair. Nature 559, 324\u2013326 (2018).","journal-title":"Nature"},{"key":"1070_CR134","doi-asserted-by":"publisher","DOI":"10.1136\/medethics-2020-106820","author":"JM Dur\u00e1n","year":"2021","unstructured":"Dur\u00e1n, J. M. & Jongsma, K. R. Who is afraid of black box algorithms? On the epistemological and ethical basis of trust in medical AI. J. Med. Ethics\u00a0https:\/\/doi.org\/10.1136\/medethics-2020-106820 (2021).","journal-title":"J. Med. Ethics"},{"key":"1070_CR135","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fdata.2020.00025","volume":"3","author":"A Baird","year":"2020","unstructured":"Baird, A. & Schuller, B. Considerations for a more ethical approach to data in AI: on data representation and infrastructure. Front. Big Data 3, 25 (2020).","journal-title":"Front. Big Data"},{"key":"1070_CR136","doi-asserted-by":"publisher","unstructured":"Chmielinski, K. S. et al. The dataset nutrition label (2nd gen): leveraging context to mitigate harms in artificial intelligence. Preprint at https:\/\/doi.org\/10.48550\/arXiv.2201.03954 (2022).","DOI":"10.48550\/arXiv.2201.03954"},{"key":"1070_CR137","doi-asserted-by":"publisher","unstructured":"Dwork, C., Hardt, M., Pitassi, T., Reingold, O. & Zemel, R. Fairness through awareness. in Proc. 3rd Innovations in Theoretical Computer Science Conference https:\/\/doi.org\/10.1145\/2090236.2090255 (ACM, 2012).","DOI":"10.1145\/2090236.2090255"},{"key":"1070_CR138","unstructured":"Bolukbasi, T., Chang, K.-W., Zou, J., Saligrama, V. & Kalai, A. Man is to computer programmer as woman is to homemaker? Debiasing word embeddings in Proc. Conference on Neural Information Processing Systems (NeurIPS) http:\/\/papers.neurips.cc\/paper\/6228-man-is-to-computer-programmer-as-woman-is-to-homemaker-debiasing-word-embeddings.pdf (NeurIPS, 2016)."},{"key":"1070_CR139","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMp1714229","volume":"378","author":"DS Char","year":"2018","unstructured":"Char, D. S., Shah, N. H. & Magnus, D. Implementing machine learning in health care \u2014 addressing ethical challenges. N. Engl. J. Med. 378, 981\u2013983 (2018).","journal-title":"N. Engl. J. Med."},{"key":"1070_CR140","unstructured":"Center for Devices and Radiological Health. Postmarket management of cybersecurity in medical devices: guidance for industry and Food and Drug Administration staff. FDA www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/postmarket-management-cybersecurity-medical-devices (2016)."},{"key":"1070_CR141","unstructured":"Wolford, B. What is GDPR, the EU\u2019s new data protection law? GDPR.EU gdpr.eu\/what-is-gdpr\/ (2018)."},{"key":"1070_CR142","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/cjp2.263","volume":"8","author":"F McKay","year":"2022","unstructured":"McKay, F. et al. The ethical challenges of artificial intelligence-driven digital pathology. J. Pathol. Clin. Res. 8, 209\u2013216 (2022).","journal-title":"J. Pathol. Clin. Res."},{"key":"1070_CR143","doi-asserted-by":"publisher","DOI":"10.1200\/CCI-24-00284","volume":"9","author":"M Roach","year":"2025","unstructured":"Roach, M. et al. Assessing algorithmic fairness with a multimodal artificial intelligence model in men of African and non-African origin on NRG oncology prostate cancer phase III trials. JCO Clin. Cancer Inform. 9, e2400284 (2025).","journal-title":"JCO Clin. Cancer Inform."},{"key":"1070_CR144","doi-asserted-by":"publisher","first-page":"e195","DOI":"10.1016\/S2589-7500(20)30292-2","volume":"3","author":"UJ Muehlematter","year":"2021","unstructured":"Muehlematter, U. J., Daniore, P. & Vokinger, K. N. Approval of artificial intelligence and machine learning-based medical devices in the USA and Europe (2015-20): a comparative analysis. Lancet Digit. Health 3, e195\u2013e203 (2021).","journal-title":"Lancet Digit. Health"},{"key":"1070_CR145","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41746-020-00324-0","volume":"3","author":"S Benjamens","year":"2020","unstructured":"Benjamens, S., Dhunnoo, P. & Mesk\u00f3, B. The state of artificial intelligence-based FDA-approved medical devices and algorithms: an online database. NPJ Digit. Med. 3, 118 (2020).","journal-title":"NPJ Digit. Med."},{"key":"1070_CR146","doi-asserted-by":"publisher","first-page":"e618","DOI":"10.1016\/S2589-7500(23)00126-7","volume":"5","author":"UJ Muehlematter","year":"2023","unstructured":"Muehlematter, U. J., Bluethgen, C. & Vokinger, K. N. FDA-cleared artificial intelligence and machine learning-based medical devices and their 510(k) predicate networks. Lancet Digit. Health 5, e618\u2013e626 (2023).","journal-title":"Lancet Digit. Health"},{"key":"1070_CR147","unstructured":"Food and Drug Administration. Proposed regulatory framework for modifications to artificial intelligence\/machine learning (AI\/ML)-based software as a medical device (SaMD): discussion paper and request for feedback. FDA www.fda.gov\/files\/medical%20devices\/published\/US-FDA-Artificial-Intelligence-and-Machine-Learning-Discussion-Paper.pdf (2019)."},{"key":"1070_CR148","unstructured":"Food and Drug Administration. Good machine learning practice for medical device development: guiding principles. FDA www.fda.gov\/medical-devices\/software-medical-device-samd\/good-machine-learning-practice-medical-device-development-guiding-principles (2025)."},{"key":"1070_CR149","unstructured":"IMDRF Software as a Medical Device (SaMD) Working Group. Software as a medical device (SaMD): possible framework for risk categorization and corresponding considerations. IMDRF www.imdrf.org\/sites\/default\/files\/docs\/imdrf\/final\/technical\/imdrf-tech-140918-samd-framework-risk-categorization-141013.pdf (2014)."},{"key":"1070_CR150","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1001\/jama.2019.16842","volume":"322","author":"TJ Hwang","year":"2019","unstructured":"Hwang, T. J., Kesselheim, A. S. & Vokinger, K. N. Lifecycle regulation of artificial intelligence- and machine learning-based software devices in medicine. JAMA 322, 2285\u20132286 (2019).","journal-title":"JAMA"},{"key":"1070_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104427","volume":"88","author":"MA Berb\u00eds","year":"2023","unstructured":"Berb\u00eds, M. A. et al. Computational pathology in 2030: a Delphi study forecasting the role of AI in pathology within the next decade. EBioMedicine 88, 104427 (2023).","journal-title":"EBioMedicine"},{"key":"1070_CR152","unstructured":"Clarke, H. CMS payment rate established for ArteraAI prostate cancer test. Urology Times www.urologytimes.com\/view\/cms-payment-rate-established-for-arteraai-prostate-cancer-test (2024)."},{"key":"1070_CR153","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4103\/2153-3539.139714","volume":"5","author":"J Ho","year":"2014","unstructured":"Ho, J. et al. Can digital pathology result in cost savings? A financial projection for digital pathology implementation at a large integrated health care organization. J. Pathol. Inform. 5, 33 (2014).","journal-title":"J. Pathol. Inform."},{"key":"1070_CR154","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41746-022-00609-6","volume":"5","author":"RB Parikh","year":"2022","unstructured":"Parikh, R. B. & Helmchen, L. A. Paying for artificial intelligence in medicine. NPJ Digit. Med. 5, 63 (2022).","journal-title":"NPJ Digit. Med."},{"key":"1070_CR155","doi-asserted-by":"publisher","first-page":"100376","DOI":"10.1016\/j.jpi.2024.100376","volume":"15","author":"O Ardon","year":"2024","unstructured":"Ardon, O. et al. Understanding the financial aspects of digital pathology: a dynamic customizable return on investment calculator for informed decision-making. J. Pathol. Inform. 15, 100376 (2024).","journal-title":"J. Pathol. Inform."},{"key":"1070_CR156","unstructured":"American Medical Association. Category III codes. AMA www.ama-assn.org\/practice-management\/cpt\/category-iii-codes (2025)."},{"key":"1070_CR157","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"1070_CR158","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.4337","volume":"2","author":"DM Metter","year":"2019","unstructured":"Metter, D. M., Colgan, T. J., Leung, S. T., Timmons, C. F. & Park, J. Y. Trends in the US and Canadian pathologist workforces from 2007 to 2017. JAMA Netw. Open\u00a02, e194337 (2019).","journal-title":"JAMA Netw. Open"},{"key":"1070_CR159","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s42256-021-00307-0","volume":"3","author":"M Roberts","year":"2021","unstructured":"Roberts, M. et al. Common pitfalls and recommendations for using machine learning to detect and prognosticate for COVID-19 using chest radiographs and CT scans. Nat. Mach. Intell. 3, 199\u2013217 (2021).","journal-title":"Nat. Mach. Intell."},{"key":"1070_CR160","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2174\/1389202922666210705124359","volume":"22","author":"H Habehh","year":"2021","unstructured":"Habehh, H. & Gohel, S. Machine learning in healthcare. Curr. Genomics 22, 291\u2013300 (2021).","journal-title":"Curr. Genomics"},{"key":"1070_CR161","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jacr.2021.06.025","volume":"19","author":"KJ Dreyer","year":"2022","unstructured":"Dreyer, K. J., Allen, B. & Wald, C. Real-world surveillance of FDA-cleared artificial intelligence models: rationale and logistics. J. Am. Coll. Radiol. 19, 274\u2013277 (2022).","journal-title":"J. Am. Coll. Radiol."},{"key":"1070_CR162","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4103\/jpi.jpi_42_18","volume":"9","author":"MD Herrmann","year":"2018","unstructured":"Herrmann, M. D. et al. Implementing the DICOM standard for digital pathology. J. Pathol. Inform. 9, 37 (2018).","journal-title":"J. Pathol. Inform."},{"key":"1070_CR163","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41746-022-00621-w","volume":"5","author":"MD Abr\u00e0moff","year":"2022","unstructured":"Abr\u00e0moff, M. D. et al. A reimbursement framework for artificial intelligence in healthcare. NPJ Digit. Med. 5, 72 (2022).","journal-title":"NPJ Digit. Med."},{"key":"1070_CR164","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-048008","volume":"11","author":"GS Collins","year":"2021","unstructured":"Collins, G. S. et al. Protocol for development of a reporting guideline (TRIPOD-AI) and risk of bias tool (PROBAST-AI) for diagnostic and prognostic prediction model studies based on artificial intelligence. BMJ Open\u00a011, e048008 (2021).","journal-title":"BMJ Open"},{"key":"1070_CR165","doi-asserted-by":"publisher","first-page":"m3164","DOI":"10.1136\/bmj.m3164","volume":"370","author":"X Liu","year":"2020","unstructured":"Liu, X. et al. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI Extension. BMJ 370, m3164 (2020).","journal-title":"BMJ"},{"key":"1070_CR166","doi-asserted-by":"publisher","first-page":"m3210","DOI":"10.1136\/bmj.m3210","volume":"370","author":"SC Rivera","year":"2020","unstructured":"Rivera, S. C. et al. Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI Extension. BMJ 370, m3210 (2020).","journal-title":"BMJ"},{"key":"1070_CR167","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1038\/s41591-020-1041-y","volume":"26","author":"B Norgeot","year":"2020","unstructured":"Norgeot, B. et al. Minimum information about clinical artificial intelligence modeling: the MI-CLAIM checklist. Nat. Med. 26, 1320\u20131324 (2020).","journal-title":"Nat. Med."}],"container-title":["Nature Reviews Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41585-025-01070-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-025-01070-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-025-01070-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T01:02:12Z","timestamp":1767747732000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41585-025-01070-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":167,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1070"],"URL":"https:\/\/doi.org\/10.1038\/s41585-025-01070-2","relation":{},"ISSN":["1759-4812","1759-4820"],"issn-type":[{"value":"1759-4812","type":"print"},{"value":"1759-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,4]]},"assertion":[{"value":"8 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.M. discloses several commercial and institutional relationships in the field of medical imaging and computational pathology. He maintains a leadership position at Inspirata and holds equity interests in both Inspirata and Elucid Bioimaging. His advisory activities include consulting roles with Merck, Aiforia, Roche, Caris Life Sciences and Cernostics, and he has received honoraria from AstraZeneca and Inspirata. His research programme benefits from institutional funding support from multiple industry partners, including Inspirata, Philips Healthcare, Bristol Myers Squibb, AstraZeneca and Boehringer Ingelheim. Additionally, A.M. reports intellectual property relationships, with patents licensed through his institution to both Inspirata Inc. and Elucid Bioimaging. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}